Yüklüyor......
Budesonide–formoterol (inhalation powder) in the treatment of COPD
The budesonide–formoterol dry powder inhaler (Symbicort(®) Turbuhaler(®) 160/4.5–640/18 μg/day) contains the long-acting β(2)-adrenoreceptor agonist formoterol and the inhaled corticosteroid budesonide. Two large, 12-month trials examined the effect of budesonide–formoterol 160/4.5 μg twice daily in...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2006
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2706613/ https://ncbi.nlm.nih.gov/pubmed/18046888 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|